| Title |
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
|
|---|---|
| Published in |
Journal of neurology, neurosurgery and psychiatry, July 2012
|
| DOI | 10.1136/jnnp-2012-302468 |
| Pubmed ID | |
| Authors |
John Peter Zajicek, Jeremy C Hobart, Anita Slade, David Barnes, Paul G Mattison, on behalf of the MUSEC Research Group |
| Abstract |
Multiple sclerosis (MS) is associated with chronic symptoms, including muscle stiffness, spasms, pain and insomnia. Here we report the results of the Multiple Sclerosis and Extract of Cannabis (MUSEC) study that aimed to substantiate the patient based findings of previous studies. |
X Demographics
The data shown below were collected from the profiles of 97 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 25 | 26% |
| Japan | 10 | 10% |
| Canada | 6 | 6% |
| United Kingdom | 3 | 3% |
| France | 2 | 2% |
| Denmark | 2 | 2% |
| Spain | 2 | 2% |
| Australia | 2 | 2% |
| Colombia | 1 | 1% |
| Other | 7 | 7% |
| Unknown | 37 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 78 | 80% |
| Practitioners (doctors, other healthcare professionals) | 9 | 9% |
| Scientists | 7 | 7% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
| Unknown | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 497 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 493 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 67 | 13% |
| Student > Master | 61 | 12% |
| Researcher | 58 | 12% |
| Other | 40 | 8% |
| Student > Ph. D. Student | 40 | 8% |
| Other | 95 | 19% |
| Unknown | 136 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 116 | 23% |
| Pharmacology, Toxicology and Pharmaceutical Science | 39 | 8% |
| Psychology | 34 | 7% |
| Agricultural and Biological Sciences | 28 | 6% |
| Neuroscience | 24 | 5% |
| Other | 96 | 19% |
| Unknown | 160 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 161. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2023.
All research outputs
#253,199
of 25,394,764 outputs
Outputs from Journal of neurology, neurosurgery and psychiatry
#78
of 7,408 outputs
Outputs of similar age
#1,149
of 177,989 outputs
Outputs of similar age from Journal of neurology, neurosurgery and psychiatry
#1
of 71 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,408 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,989 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.